- Home
- HOWL vs WYY Comparison
HOWL vs WYY Comparison
Compare HOWL & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- WYY
- Stock Information
- Founded
- HOWL 2017
- WYY 1991
- Country
- HOWL United States
- WYY United States
- Employees
- HOWL N/A
- WYY N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- WYY EDP Services
- Sector
- HOWL Health Care
- WYY Technology
- Exchange
- HOWL Nasdaq
- WYY Nasdaq
- Market Cap
- HOWL 64.5M
- WYY 55.2M
- IPO Year
- HOWL 2021
- WYY 1998
- Fundamental
- Price
- HOWL $1.40
- WYY $5.44
- Analyst Decision
- HOWL Strong Buy
- WYY Strong Buy
- Analyst Count
- HOWL 5
- WYY 2
- Target Price
- HOWL $7.20
- WYY $7.50
- AVG Volume (30 Days)
- HOWL 151.8K
- WYY 77.7K
- Earning Date
- HOWL 11-06-2025
- WYY 11-12-2025
- Dividend Yield
- HOWL N/A
- WYY N/A
- EPS Growth
- HOWL N/A
- WYY N/A
- EPS
- HOWL N/A
- WYY N/A
- Revenue
- HOWL N/A
- WYY $144,421,640.00
- Revenue This Year
- HOWL N/A
- WYY $9.19
- Revenue Next Year
- HOWL N/A
- WYY $13.16
- P/E Ratio
- HOWL N/A
- WYY N/A
- Revenue Growth
- HOWL N/A
- WYY 16.25
- 52 Week Low
- HOWL $0.60
- WYY $2.19
- 52 Week High
- HOWL $4.18
- WYY $6.25
- Technical
- Relative Strength Index (RSI)
- HOWL 56.16
- WYY 71.20
- Support Level
- HOWL $1.38
- WYY $5.26
- Resistance Level
- HOWL $1.49
- WYY $5.40
- Average True Range (ATR)
- HOWL 0.07
- WYY 0.29
- MACD
- HOWL 0.00
- WYY 0.01
- Stochastic Oscillator
- HOWL 55.00
- WYY 71.82
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.